Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company ...

In a report released today, Michael Matson from Needham reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Stryker (SYK – Research Report), with a price target of ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...